James Doyle, PhD
CHIEF EXECUTIVE OFFICER
James Doyle obtained his Ph.D. in Experimental Medicine from McGill University in Montreal, Canada. His research interests focus on developing new models to study rare disorders in the nematode Caenorhabditis elegans and zebrafish. He used these models to discover fundamental information about the disease processes, uncovering new therapeutic targets in the process. James was also involved in the design and application of cutting-edge methods to accelerate the drug discovery process and to investigate disease pathology. Being exposed first-hand to research into rare diseases, he saw the lack of information known about them, and quickly realized the need to streamline the process of translating genetic data into therapeutic discoveries.